# artbio.com

> AI-optimized mirror of artbio.com containing 11 pages totalling 8,061 words of clean markdown content, structured data, and semantic HTML. Original source: https://artbio.com. Last updated: 2026-07-26T02:04:01.166Z.

Each page is available as HTML (with JSON-LD structured data) and Markdown (text-only, ideal for LLMs and RAG).

## Homepage

- [ARTBIO](/content/site-root.html): Learn about how ARTBIO is redefining cancer care through a new class of alpha radioligand therapies and building an ecosystem to maximize their potential. (975 words)

## Articles & Blog Posts

- [Terms Of Service](/content/terms-of-service/index.html): ARTBIO is redefining cancer care by developing a new class of alpha radioligand therapies (ART) and building the ecosystem that maximizes their potential. At ARTBIO, we put the patient at the core of everything we do. (2,877 words)
- [Privacy Policy](/content/privacy-policy/index.html): ARTBIO is redefining cancer care by developing a new class of alpha radioligand therapies (ART) and building the ecosystem that maximizes their potential. At ARTBIO, we put the patient at the core of everything we do. (898 words)
- [ARTBIO Announces Dosing of Two Cohorts with AB001 in ARTISAN, a Phase 1 Alpha Radioligand Therapy Clinical Trial for Metastatic Castration Resistant Prostate Cancer](/content/artbio-announces-dosing-of-two-cohorts-with-ab001/index.html): ARTBIO is redefining cancer care by developing a new class of alpha radioligand therapies (ART) and building the ecosystem that maximizes their potential. At ARTBIO, we put the patient at the core of everything we do. (552 words)
- [Industry Veteran Jonathan Freeman, Ph.D. Joins ARTBIO As Chief Business Officer](/content/jonathan-freeman-joins-artbio-as-chief-business-office.html): ARTBIO is redefining cancer care by developing a new class of alpha radioligand therapies (ART) and building the ecosystem that maximizes their potential. At ARTBIO, we put the patient at the core of everything we do. (430 words)
- [ARTBIO Appoints Jonathan Freeman Interim Chief Executive Officer](/content/artbio-appoints-jonathan-freeman-interim-ceo/index.html): ARTBIO is redefining cancer care by developing a new class of alpha radioligand therapies (ART) and building the ecosystem that maximizes their potential. At ARTBIO, we put the patient at the core of everything we do. (258 words)
- [AlphaGen Therapeutics and ARTBIO Announce Exclusive Strategic Collaboration for the Development and Commercialization of AB001 in Greater China and on ARTBIO’s 212Pb AlphaDirect™ Technology](/content/alphagen-therapeutics-and-artbio-announce-exclusive-strategic-collaboration-for-the-development-and-commercialization-of-ab001-in-greater-china-and-on-artbio-e2-80-99s-212pb-alphadirect-e2-84-a2-technology.html): ARTBIO is redefining cancer care by developing a new class of alpha radioligand therapies (ART) and building the ecosystem that maximizes their potential. At ARTBIO, we put the patient at the core of everything we do. (665 words)
- [ARTBIO Announces $132 Million Series B Financing to Advance Pipeline of Alpha Radioligand Therapies and Expand Manufacturing and Supply Chain Infrastructure](/content/artbio-raises-132m-series-b-to-advance-alpha-radioligand-therapies-and-expand-infrastructure.html): ARTBIO is redefining cancer care by developing a new class of alpha radioligand therapies (ART) and building the ecosystem that maximizes their potential. At ARTBIO, we put the patient at the core of everything we do. (588 words)
- [Clinical Trials](/content/clinical-trials/index.html): ARTBIO is redefining cancer care by developing a new class of alpha radioligand therapies (ART) and building the ecosystem that maximizes their potential. At ARTBIO, we put the patient at the core of everything we do. (38 words)
- [Our Approach](/content/our-approach/index.html): Discover more about the unique ARTBIO that harneses the power of ARTs and overcomes the challenges seen with radioligand therapies. (554 words)
- [ARTBIO Implements Voluntary Clinical Hold of ARTISAN Trial for Lead Asset AB001](/content/artbio-implements-voluntary-clinical-hold-artisan-trial-ab001.html): ARTBIO is redefining cancer care by developing a new class of alpha radioligand therapies (ART) and building the ecosystem that maximizes their potential. At ARTBIO, we put the patient at the core of everything we do. (226 words)

## Resources

- [Full Page Index](/index.html): Browse all cached pages with rich metadata
- [About This Cache](/content/about.html): Methodology, technical details, and usage guidelines
- [XML Sitemap](/sitemap.xml): Machine-readable sitemap for crawler discovery
- [Robots.txt](/robots.txt): Crawler directives